7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

Volver a Agenda

[Session 7] Abstract Session 2

Session Chair(s)

Yasunari Kanda, PHD

Head of Division of Pharmacology, National Institute of Health Sciences, Japan

Kaori Shinagawa, MD, PHD

Senior Scientist for Clinical Medicine, Office of New Drug II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

Takako Morooka

Department of Medical Technique, Nagoya University Hospital, Japan

A Case of Spontaneous Smoking Echo in a Patient with Bladder and Pancreatic Cancer - Detection of Prothrombotic Status with Echocardiography

Jeff Heilbraun, MS

Vice President, Medical and Scientific Affairs, Cardiology, Clario, United States

Blood Pressure Monitoring in Clinical Trials - from Efficacy to Safety Endpoints - Design and Technology Considerations

¿Tiene una cuenta?